| 1 | ARWRARROWHEAD PHARMACEUTICALS, INC. | 100 | 23258% | -44% | $11.8B | — |
| 2 | MDGLMADRIGAL PHARMACEUTICALS, INC. | 99 | 432% | -27% | $12.2B | — |
| 3 | ASNDAscendis Pharma A/S | 98 | 98% | -32% | $18.0B | — |
| 4 | ALNYALNYLAM PHARMACEUTICALS, INC. | 97 | 65% | 8% | $41.8B | 6 |
| 5 | KRYSKrystal Biotech, Inc. | 96 | 34% | 54% | $11.1B | — |
| 6 | LLYELI LILLY & Co | 95 | 45% | 32% | $1.1T | 8 |
| 7 | NVMINOVA LTD. | 94 | 31% | 29% | $15.0B | 3 |
| 8 | AXSMAxsome Therapeutics, Inc. | 93 | 66% | -27% | $12.6B | — |
| 9 | KLACKLA CORP | 92 | 24% | 36% | $307.7B | 9 |
| 10 | ONCBeOne Medicines Ltd. | 91 | 40% | 5% | $30.9B | 7 |
| 11 | BBIOBridgeBio Pharma, Inc. | 90 | 126% | -126% | $15.1B | 2 |
| 12 | RPRXRoyalty Pharma plc | 89 | 5% | 56% | $25.6B | — |
| 13 | ISRGINTUITIVE SURGICAL INC | 88 | 21% | 28% | $150.9B | 6 |
| 14 | INCYINCYTE CORP | 88 | 21% | 25% | $23.3B | 8 |
| 15 | UTHRUNITED THERAPEUTICS Corp | 87 | 11% | 41% | $23.6B | 8 |
| 16 | PODDINSULET CORP | 86 | 31% | 10% | $11.4B | 6 |
| 17 | GMABGENMAB A/S | 85 | 19% | 26% | $17.5B | — |
| 18 | NBIXNEUROCRINE BIOSCIENCES INC | 84 | 21% | 22% | $17.5B | 6 |
| 19 | VRTXVERTEX PHARMACEUTICALS INC / MA | 83 | 9% | 36% | $134.0B | 6 |
| 20 | HUMHUMANA INC | 82 | 32% | 1% | $47.6B | — |
| 21 | MEDPMedpace Holdings, Inc. | 81 | 20% | 17% | $15.9B | — |
| 22 | BSXBOSTON SCIENTIFIC CORP | 80 | 20% | 17% | $67.1B | 8 |
| 23 | NTRANatera, Inc. | 79 | 36% | -9% | $40.0B | — |
| 24 | BTSGBrightSpring Health Services, Inc. | 78 | 28% | 2% | $13.5B | 7 |
| 25 | EXELEXELIXIS, INC. | 77 | 7% | 34% | $14.0B | 6 |